Clinical Trial Update: A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial of motexafin gadolinium for chronic lymphocytic leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Leukemia, Leukemia, Lymphocytic, Chronic | Phase 2 | Status: TERMINATED